주식/증권 📈 긍정적 Haemonetics projects FY 2027 revenue growth of 4% to 7% as Persona PLUS rollout and IVT rebound efforts continue Seeking Alpha - Market News 2026/05/08 06:42:50 65회 원문 기사 보기